Corvex Management LP filed a Form 144 notice on November 3, 2026, disclosing a proposed sale of 369,501 shares of Illumina, Inc. common stock through Goldman Sachs & Co. LLC on the Nasdaq Stock Market.

Key Highlights

  • Proposed sale: Corvex Management LP filed notice to sell 369,501 shares of Illumina, Inc. common stock, with an aggregate market value of $87,198,540.99.
  • Broker named: Goldman Sachs & Co. LLC, located at 200 West Street, New York, NY 10282, is listed as the named broker for the proposed transaction.
  • Shares outstanding: According to the filing, 151,200,000 shares of Illumina common stock were outstanding at the time of the notice.
  • Original acquisition: The shares proposed for sale were acquired on October 25, 2023 through open market purchases, with payment made in cash on the same date.
  • Affiliate relationship: Corvex is identified as an affiliate of a director; Keith Meister, general partner controller of Corvex, serves as a director on Illumina's Board of Directors.
  • Prior three-month sales: The filing discloses twelve separate sales of Illumina common stock by Corvex between August 4, 2026 and November 3, 2026, as required by Rule 144.

Corvex Management's Proposed Sale and Prior Transaction History for Illumina Common Stock

According to the Form 144 notice filed with the U.S. Securities and Exchange Commission on November 3, 2026, Corvex Management LP proposed to sell 369,501 shares of Illumina, Inc. (NASDAQ:ILMN) common stock, par value $0.01 per share. The filing identifies the approximate date of sale as November 3, 2026, with Goldman Sachs & Co. LLC serving as the broker. Illumina, Inc. is headquartered at 5200 Illumina Way, San Diego, California 92122, and is a provider of genomic sequencing and array-based technologies.

The filing states that the shares proposed for sale were acquired on October 25, 2023 through "purchases of shares of Common Stock in the open market," with cash paid in full on the date of purchase. A remark in the filing further notes that the shares to be sold "were purchased between October 25, 2023 and March 27, 2025 in various open market transactions." Corvex Management LP is described as holding shares on behalf of one or more funds for which it serves as investment adviser.

As required under Rule 144, the filing also discloses sales of Illumina common stock by Corvex during the three months preceding the notice. The filing lists eleven sales between August 4, 2026 and September 4, 2026, as well as one sale on November 3, 2026, covering amounts ranging from 30,499 to 457,858 shares per transaction, with individual gross proceeds figures provided for each date. The filing was signed by Patrick Dooley as authorized signatory of Corvex Management LP.

What Was Disclosed

Corvex Management LP, an affiliate of an Illumina director, submitted a Form 144 notice proposing to sell 369,501 shares of Illumina, Inc. common stock with an aggregate market value of $87,198,540.99, through Goldman Sachs & Co. LLC on the Nasdaq Stock Market, with an approximate sale date of November 3, 2026.